Rheumatoid arthritis pathophysiology: Difference between revisions

Jump to navigation Jump to search
Line 35: Line 35:
===Pathogenesis===
===Pathogenesis===
*[[Rheumatoid arthritis]] is mediated by the combination of a predisposing genotype upon which genetic factors, environmental and microorganism resulting in the inflammatory and destruction of the synovial membrane.
*[[Rheumatoid arthritis]] is mediated by the combination of a predisposing genotype upon which genetic factors, environmental and microorganism resulting in the inflammatory and destruction of the synovial membrane.
*'''Environmental factors''': It causes repeated activation of innate immunity at mucosal surfaces.
'''Environmental factors''': It causes repeated activation of innate immunity at mucosal surfaces.
***Smoking interacts with genes to increase susceptibility up to 20- to 40-fold.
**Smoking interacts with genes to increase susceptibility up to 20- to 40-fold.
****Smoking causes increased expression of peptidyl arginine deiminase (PAD)  in alveolar macrophages.  
***Smoking causes increased expression of peptidyl arginine deiminase (PAD)  in alveolar macrophages.  
****Peptidyl arginine deiminase convert arginine to citrulline in the airway which further creates neoantigens that can be recognized by the adaptive immune system.
***Peptidyl arginine deiminase convert arginine to citrulline in the airway which further creates neoantigens that can be recognized by the adaptive immune system.
'''Microrganism'''
**Genetics factors like  class II major histocompatibility complex (MHC), most common human leukocyte antigen (HLA)-DR
**Genetics factors like  class II major histocompatibility complex (MHC), most common human leukocyte antigen (HLA)-DR



Revision as of 16:01, 23 March 2018

Rheumatoid arthritis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Rheumatoid arthritis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgical Therapy

Primary prevention

Secondary prevention

Future or Investigational Therapies

Case Studies

Case #1

Rheumatoid arthritis pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Rheumatoid arthritis pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

National Guidelines Clearinghouse

NICE Guidance

FDA on Rheumatoid arthritis pathophysiology

CDC on Rheumatoid arthritis pathophysiology

Rheumatoid arthritis pathophysiology in the news

Blogs onRheumatoid arthritis pathophysiology

Directions to Hospitals Treating Rheumatoid arthritis

Risk calculators and risk factors for Rheumatoid arthritis pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Manpreet Kaur, MD [2]

Overview

The exact pathogenesis of [disease name] is not fully understood.

OR

It is thought that [disease name] is the result of / is mediated by / is produced by / is caused by either [hypothesis 1], [hypothesis 2], or [hypothesis 3].

OR

[Pathogen name] is usually transmitted via the [transmission route] route to the human host.

OR

Following transmission/ingestion, the [pathogen] uses the [entry site] to invade the [cell name] cell.

OR


[Disease or malignancy name] arises from [cell name]s, which are [cell type] cells that are normally involved in [function of cells].

OR

The progression to [disease name] usually involves the [molecular pathway].

OR

The pathophysiology of [disease/malignancy] depends on the histological subtype.

Pathophysiology

Pathogenesis

  • Rheumatoid arthritis is mediated by the combination of a predisposing genotype upon which genetic factors, environmental and microorganism resulting in the inflammatory and destruction of the synovial membrane.

Environmental factors: It causes repeated activation of innate immunity at mucosal surfaces.

    • Smoking interacts with genes to increase susceptibility up to 20- to 40-fold.
      • Smoking causes increased expression of peptidyl arginine deiminase (PAD) in alveolar macrophages.
      • Peptidyl arginine deiminase convert arginine to citrulline in the airway which further creates neoantigens that can be recognized by the adaptive immune system.

Microrganism

    • Genetics factors like class II major histocompatibility complex (MHC), most common human leukocyte antigen (HLA)-DR

Genetics

  • [Disease name] is transmitted in [mode of genetic transmission] pattern.
  • Genes involved in the pathogenesis of [disease name] include [gene1], [gene2], and [gene3].
  • The development of [disease name] is the result of multiple genetic mutations.

Associated Conditions

Gross Pathology

  • On gross pathology, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].

Microscopic Pathology

  • On microscopic histopathological analysis, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].

References

Template:WH Template:WS